| Patents for C07J 51 - Normal steroids with unmodified cyclopenta[a]hydrophenanthrene skeleton not provided for in groups (1,565) |
|---|
| 06/11/2002 | US6403786 Compounds used to label, detect and sequence nucleic acids |
| 06/04/2002 | US6399767 Intermediates for the synthesis of vitamin D and steroid derivatives and process for preparation thereof |
| 05/30/2002 | WO2001042273A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/28/2002 | US6395713 Cationic lipidcationic lipid |
| 05/28/2002 | US6395492 Derivatized oligonucleotides having improved uptake and other properties |
| 05/07/2002 | US6384250 Process for the preparation of (E,Z) 3-(2-aminoethoxyimino)-androstane-6, 17-dione and its analogues |
| 05/07/2002 | US6384025 Skin disorders; reacting retinol with chloroformate compound |
| 05/02/2002 | WO2001040253A3 3-methylene steroid derivative for the treatment of autoimmune diseases |
| 05/02/2002 | EP0615448B1 Sex steroid activity inhibitors |
| 04/09/2002 | US6369247 Process for oxidation of steroidal compounds having allylic groups |
| 04/03/2002 | EP0988312B1 17beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis |
| 03/28/2002 | WO2001066560A3 Novel derivatives comprising phytosterols and/or phytostanols and alpha-lipoic and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders |
| 03/27/2002 | EP1189924A1 Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 03/21/2002 | WO2002022645A2 Method of making 7alpha-methyl-11beta-methoxy estradiol and related compounds with estrogenic activity |
| 03/06/2002 | CN1338462A Chemical synthesis of echinocystic saponin derivative |
| 02/28/2002 | US20020025951 Urogenital disorders |
| 02/14/2002 | US20020019547 Skin disorders; reacting retinol with chloroformate compound |
| 02/13/2002 | EP1179005A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 02/13/2002 | EP1178994A1 Improved process for phosphorylation and compounds produced by this process |
| 02/07/2002 | WO2002010188A1 16alpha-methyl or ethyl substituted estrogens |
| 01/29/2002 | US6342489 Treatment of iron deficiency with ferric salt of bis hemisuccinylursodeoxycholic acid |
| 01/22/2002 | CA2049882C Process for iodinating or brominating the alpha-methylenic carbon of a secondary amide |
| 01/02/2002 | EP1167364A1 Benzopyran-containing compounds and prodrug forms thereof |
| 12/27/2001 | US20010056182 Process for the preparation of (E,Z) 3-(2-aminoethoxyimino)-androstane-6,17-dione and its analogues |
| 12/27/2001 | US20010056074 Novel lipophilic compounds having affinity with nucleic acids and therapeutical uses thereof |
| 12/18/2001 | US6331535 Retinyl carbonate derivatives, preparation process and uses |
| 12/12/2001 | EP0806413B1 2-substituted vitamin d3 derivatives |
| 12/05/2001 | EP0749437B1 Pharmaceutical uses of steroid derivatives |
| 11/28/2001 | EP0912599B1 Diglycerid and sterol based organometallic complexes and pharmaceutical compositions and dietetic products containing them |
| 11/28/2001 | EP0906332B1 7alpha-(5-methylaminopentyl)-estratrienes, process for the preparation thereof, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl)-estratrienes and use thereof for production of drugs |
| 11/27/2001 | CA2025294C Bile acid derivatives, processes for their preparation, and use as pharmaceuticals |
| 11/21/2001 | EP1156058A2 Process for the preparation of (E,Z) 3-(2-aminoethoxyimino)-androstane-6,17-dione and its analogues |
| 11/21/2001 | EP1155023A1 Chelating compounds and their complexes with paramagnetic metals |
| 11/15/2001 | WO2001085755A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity |
| 11/15/2001 | CA2408751A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity |
| 10/10/2001 | EP1140972A1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 10/04/2001 | EP0529002B1 Fluorescent porphyrin, and fluorescent phthalocyanine - polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes |
| 10/02/2001 | US6297228 Use of angiostatic steroids in photodynamic therapy |
| 09/26/2001 | EP1135404A1 Sterol phosphates used as deodorant substances |
| 09/26/2001 | EP0528991B1 Detectably labelled marker component comprising a fluorophore moiety , fluorescent probe comprising the marker component and uses thereof. |
| 09/19/2001 | EP0728140B1 New steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances |
| 09/13/2001 | WO2001066560A2 Novel derivatives comprising phytosterols and/or phytostanols and alpha-lipoic and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders |
| 09/11/2001 | US6288051 Estrogen-dependent breast cancer treatment |
| 08/29/2001 | CN1310721A Medicine nitrate salts |
| 08/28/2001 | CA2191324C Process for preparing .delta.9,11 and 21-chloro corticosteroids |
| 08/21/2001 | US6277838 Methods for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| 08/14/2001 | CA2014545C Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 07/24/2001 | US6265558 Compound of linked nucleosides having thiol group attatched at 5-pyrimidine or 2-, 6-, or 8-purine positions; attachment reporter molecules, reporter enzymes, steroids, lipophilic molecules, peptides, proteins and other groups |
| 07/17/2001 | US6262282 17β-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis |
| 07/11/2001 | CN1068333C Sterol derivatives used as regulation of meiosis |
| 07/10/2001 | US6258803 11-ethyl-17-hydroxy-19-norpregn-4-en-20-yn-3-one for menopause treatment |
| 06/28/2001 | WO2001046207A1 Chelating compounds, their complexes with paramagnetic metals |
| 06/26/2001 | US6251939 Carbamate-based cationic lipids |
| 06/26/2001 | US6251887 17β-aryl(arylmethyl)oxy(thio)alkyl-androstane derivatives |
| 06/14/2001 | WO2001042273A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/07/2001 | WO2001040253A2 3-methylene steroid derivative for the treatment of autoimmune diseases |
| 06/07/2001 | CA2391096A1 3-methylene steroid derivatives |
| 05/23/2001 | EP1100805A1 Medicine nitrate salts |
| 03/15/2001 | WO2001018027A1 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 02/27/2001 | CA2081205C Steroids which inhibit angiogenesis |
| 02/14/2001 | EP0663924B1 17-beta-carboxanilides of 4-aza-5-alpha-androstan-3-ones as 5-alpha-reductase inhibitors |
| 01/24/2001 | EP1070082A1 Method for producing 4,4-dimethyl-5alpha-cholesta-8,14,24-triene-3beta-ol and intermediate products obtained by said method |
| 01/23/2001 | US6177461 Hypotensive agent; therapy for premenstual tension, preeclampsia and polycyclic kidney disease |
| 01/23/2001 | US6177420 Fertility control agents; side effect reduction |
| 01/09/2001 | US6172049 Supplying macromolecules to cells |
| 01/04/2001 | WO2001000653A1 Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 01/04/2001 | CA2377492A1 Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 12/27/2000 | EP0716604A4 Thiol-derivatized nucleosides and oligonucleosides |
| 12/06/2000 | EP1057809A1 Carbonate derivatives of retinol, process for their preparation and utilisations |
| 12/06/2000 | CN1275989A Bile acid salts of metals with physiological action and the use thereof in therapy |
| 11/23/2000 | WO2000069865A1 Improved process for phosphorylation and compounds produced by this process |
| 11/16/2000 | WO2000068246A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 11/16/2000 | CA2373443A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 11/09/2000 | WO2000066613A1 Bone targeting agents for osteoporosis |
| 11/07/2000 | US6143736 Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| 10/31/2000 | US6140518 For use in the prevention or treatment of osteoporosis and related bone disorders. |
| 10/17/2000 | US6133038 Diagnostic kit includes container with platinum-based linker compound and container with detectable marker moiety; for preparation of labeled probes |
| 10/11/2000 | EP1042353A1 17beta-aryl (arylmethyl) oxy(thio)alkyl -androstane derivatives |
| 10/11/2000 | CN1057305C Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceuticals |
| 10/10/2000 | US6130212 Use of novel organoselenium compounds as pro-oxidizing agents, their methods of preparation and pharmaceutical compositions and application thereof |
| 10/10/2000 | US6130211 Phosphocholinate cardenolides |
| 10/10/2000 | US6129924 Diglyceride and sterol based organometallic complexes and pharmaceutical compositions and dietetic products containing them |
| 10/04/2000 | EP1039912A1 Angiostatic agents and compositions for controlling ocular hypertension |
| 09/27/2000 | EP1038880A2 Androstanes and pregnanes for allosteric modulation of GABA receptor |
| 09/27/2000 | CN1268174A Catalytic monoclonal antibodies for the vivo transformation of corticosteroid prodrugs |
| 09/20/2000 | EP1036088A1 Method of preparing 16 alpha,17 alpha-dialkylated steroids |
| 09/05/2000 | US6114513 Medical diagnosis; transfer across cell membranes |
| 08/29/2000 | US6110906 Androgen derivatives for use in the inhibition of sex steroid activity |
| 08/23/2000 | EP0759929B1 Oxidation of steroids having allylic groups |
| 08/23/2000 | EP0752860B1 Androstanes and pregnanes for allosteric modulation of gaba receptor |
| 08/22/2000 | US6107036 Heterocyclic dioxethane substrates, process for their preparation and their use |
| 08/16/2000 | EP0755922B1 22-thiavitamin d3 derivative |
| 08/02/2000 | EP1024146A1 The use of steroid saponin compounds to prevent senility, and novel steroid saponin compounds |
| 08/02/2000 | EP1023314A1 Bile acid salts of metals with physiological action and the use thereof in therapy |
| 08/02/2000 | CN1261892A Diphosphonic acid salts for treatment of osteoporsis |
| 07/19/2000 | EP1019365A1 Novel compositions for the delivery of negatively charged molecules |
| 07/19/2000 | CN1260802A 20-aralkyl-5 'alpha'-pregnane derivatives |
| 07/06/2000 | WO2000039148A1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 07/05/2000 | EP0900234B1 21-substituted progesterone derivatives as new antiprogestational agents |
| 07/05/2000 | EP0554436B1 Gaba receptor modulators |